Skeletal Muscle Ultrasonography in Children with a Dysfunction in the Oxidative Phosphorylation System

Abstract

Objective: The aim of this prospective study was to investigate the diagnostic value of quantitative skeletal muscle ultrasonography in children suspected of having a mitochondrial disorder. Methods: Muscle thickness and quantitatively determined echo intensity of four muscles were established in 53 children with symptoms indicative of a mitochondrial disorder. Results: A sensitivity of 25 to 46 % was found, depending on the chosen cut-off point (abnormal or borderline abnormal), with a specificity of 85 to 100 %. Except for one, all abnormal ultrasound scans were found in children over five years of age. Within the group of patients with a mitochondrial disorder, a significant correlation was found between muscle echo intensity and age (r = 0.38; p = 0.047). Conclusions: We conclude that skeletal muscle ultrasound can be of additional value in the diagnosis of children with suspected mitochondrial disorders, especially in children over five years of age. With its low sensitivity, it is not suitable for screening purposes. However, since all abnormal ultrasound scans were found in children with a mitochondrial disorder, and no significant correlation with the MDC score was found, muscle ultrasound can be used complementary to this scoring system to facilitate the decision-making in pursuing further invasive diagnostics.

Introduction

Key words

Mitochondrial disorders - muscle ultrasound - children - diagnostic value

References

• 1 Chan W P, Liu G C. MR imaging of primary skeletal muscle diseases in children.  AJR Am J Roentgenol. 2002;  179 989-997
• 2 Feinstein A R. Clinical Epidemiology the Architecture of Clinical Research. Philadelphia; W. B. Sauders Company 1985: 597-631
• 3 Fischer A Q, Carpenter D W, Hartlage P L, Carroll J E, Stephens S. Muscle imaging in neuromuscular disease using computerized real-time sonography.  Muscle Nerve. 1988;  11 270-275
• 4 Fleckenstein J L. MRI of neuromuscular disease: the basics.  Semin Musculoskelet Radiol. 2000;  4 393-419
• 5 Fleckenstein J L, Haller R G, Girson M S, Peshock R M. Focal muscle lesion in mitochondrial myopathy: MR imaging evaluation.  J Magn Reson Imaging. 1992;  2 121
• 6 Fleckenstein J L, Reimers C D. Inflammatory myopathies: radiologic evaluation.  Radiol Clin North Am. 1996;  34 427-439
• 7 Heckmatt J Z, Dubowitz V, Leeman S. Detection of pathological change in dystrophic muscle with B-scan ultrasound imaging.  Lancet. 1980;  1 1389-1390
• 8 Heckmatt J Z, Leeman S, Dubowitz V. Ultrasound imaging in the diagnosis of muscle disease.  J Pediatr. 1982;  101 656-660
• 9 Heckmatt J Z, Pier N, Dubowitz V. Real-time ultrasound imaging of muscles.  Muscle Nerve. 1988;  11 56-65
• 10 Janssen A J, Smeitink J A, van den Heuvel L P. Some practical aspects of providing a diagnostic service for respiratory chain defects.  Ann Clin Biochem. 2003;  40 3-8
• 11 Janssen A J, Trijbels F J, Sengers R C, Wintjes L T, Ruitenbeek W, Smeitink J A. et al . Measurement of the energy-generating capacity of human muscle mitochondria: diagnostic procedure and application to human pathology.  Clin Chem. 2006;  52 860-871
• 12 Jongpiputvanich S, Sueblinvong T, Norapucsunton T. Mitochondrial respiratory chain dysfunction in various neuromuscular diseases.  J Clin Neurosci. 2005;  12 426-428
• 13 Kang D, Hamasaki N. Alterations of mitochondrial DNA in common diseases and disease states: aging, neurodegeneration, heart failure, diabetes, and cancer.  Curr Med Chem. 2005;  12 429-441
• 14 Karppa M, Mahjneh I, Karttunen A, Tolonen U, Majamaa K. Muscle computed tomography patterns in patients with the mitochondrial DNA mutation 3243A > G.  J Neurol. 2004;  251 556-563
• 15 Lovitt S, Marden F A, Gundogdu B, Ostrowski M L. MRI in myopathy. [Review].  Neurol Clin. 2004;  22 509-538
• 16 Mitsui T, Kawai H, Nagasawa M, Kunishige M, Akaike M, Kimura Y. et al . Oxidative damage to skeletal muscle DNA from patients with mitochondrial encephalomyopathies.  J Neurol Sci. 1996;  139 111-116
• 17 Morava E, Dinopoulos A, Kroes H Y, Rodenburg R J, van Bokhoven H, van den Heuvel L P. et al . Mitochondrial dysfunction in a patient with Joubert syndrome.  Neuropediatrics. 2005;  36 214-217
• 18 Olsen D B, Langkilde A R, Orngreen M C, Rostrup E, Schwartz M, Vissing J. Muscle structural changes in mitochondrial myopathy relate to genotype.  J Neurol. 2003;  250 1328-1334
• 19 Pillen S, Scholten R R, Zwarts M J, Verrips A. Quantitative skeletal muscle ultrasonography in children with suspected neuromuscular disease.  Muscle Nerve. 2003;  27 699-705
• 20 Reichmann H, Gold R, Meurers B, Naumann M, Seibel P, Walter U. et al . Progression of myopathology in Kearns-Sayre syndrome: a morphological follow-up study.  Acta Neuropathol (Berl). 1993;  85 679-681
• 21 Reimers C D, Finkenstaedt M. Muscle imaging in inflammatory myopathies.  Curr Opin Rheumatol. 1997;  9 475-485
• 22 Reimers K, Reimers C D, Wagner S, Paetzke I, Pongratz D E. Skeletal muscle sonography: a correlative study of echogenicity and morphology.  J Ultrasound Med. 1993;  12 73-77
• 23 Schaefer A M, Taylor R W, Turnbull D M, Chinnery P F. The epidemiology of mitochondrial disorders-past, present and future.  Biochim Biophys Acta. 2004;  1659 115-120
• 24 Scholten R R, Pillen S, Verrips A, Zwarts M J. Quantitative ultrasonography of skeletal muscles in children: normal values.  Muscle Nerve. 2003;  27 693-698
• 25 Smeitink J, van den H L, DiMauro S. The genetics and pathology of oxidative phosphorylation.  Nat Rev Genet. 2001;  2 342-352
• 26 Thorburn D R. Mitochondrial disorders: prevalence, myths and advances.  J Inherit Metab Dis. 2004;  27 349-362
• 27 Ushmorov A, Hack V, Droge W. Differential reconstitution of mitochondrial respiratory chain activity and plasma redox state by cysteine and ornithine in a model of cancer cachexia.  Cancer Res. 1999;  59 3527-3534
• 28 Uusimaa J, Remes A M, Rantala H, Vainionpaa L, Herva R, Vuopala K. et al . Childhood encephalopathies and myopathies: a prospective study in a defined population to assess the frequency of mitochondrial disorders.  Pediatrics. 2000;  105 598-603
• 29 Wijnhoven J H, Janssen A J, van Kuppevelt T H, Rodenburg R J, Dekhuijzen P N. Metabolic capacity of the diaphragm in patients with COPD.  Respir Med. 2006;  100 1064-1071
• 30 Wolf N I, Smeitink J A. Mitochondrial disorders: a proposal for consensus diagnostic criteria in infants and children.  Neurology. 2002;  59 1402-1405
• 31 Wortmann R L, DiMauro S. Differentiating idiopathic inflammatory myopathies from metabolic myopathies.  Rheum Dis Clin North Am. 2002;  28 759-778
• 32 Zuberi S M, Matta N, Nawaz S, Stephenson J B, McWilliam R C, Hollman A. Muscle ultrasound in the assessment of suspected neuromuscular disease in childhood.  Neuromuscul Disord. 1999;  9 203-207